Structure Therapeutics welcomed Tao Chen as a new employee.
Published
Signal category
People
Quote
“I have joined Structure Therapeutics!”
— Tao Chen|Structure Therapeutics team
Company
Structure Therapeutics
Developing accessible oral small molecule therapies for the treatment of chronic diseases including obesity.
- Industry
- Biotechnology Research
- Location
- South San Francisco, US
- Company size
- 256 employees
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.
Founded 2017